Format

Send to

Choose Destination
Eur J Cancer. 2018 Apr;93:147-149. doi: 10.1016/j.ejca.2018.01.062. Epub 2018 Feb 12.

Benefit of the nivolumab and ipilimumab combination in pretreated advanced melanoma.

Author information

1
Department of Dermatology, AP-HP, Hôpital Saint-Louis, Paris, France. Electronic address: pauline.tetu@hotmail.fr.
2
Department of Dermatology, University Hospital Zurich, Zurich, Switzerland.
3
Department of Dermatology, Bordeaux, France.
4
Department of Dermatology, Le Mans, France.
5
Centre de Recherche en Cancérologie de Lyon, Institut de Cancérologie des Hospices Civils de Lyon, Université de Lyon, Lyon, France.
6
Department of Dermatology, Université Paul Sabatier, Institut Universitaire du Cancer de Toulouse-Oncopole et CHU Larrey, Toulouse, France.
7
Biostatistics, AP-HP, Hôtel-Dieu Hospital, Paris, France.
8
Department of Oncology, Lausanne University Hospital, Lausanne, Switzerland.
9
APHP Dermatology, Department of Dermatology and CIC, Paris 7 Diderot University, INSERM U976, Hôpital Saint-Louis, Paris, France.
PMID:
29449059
DOI:
10.1016/j.ejca.2018.01.062
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center